Clinical utility of postchemoradiation endoscopic brush cytology and biopsy in predicting residual esophageal adenocarcinoma

Cancer Cytopathology

Volumn 117, Issue 6, 2009, Pages 463-472

  Peng, Hong Qi ^a   Halsey, Kevin ^a   Sun, Chen Chih J ^a   Manucha, Varsha ^b   Nugent, Summer ^a   Rodgers, William H ^c   Suntharalingam, Mohan ^a   Greenwald, Bruce D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b SIR GANGA RAM HOSPITAL   (India)

^c LENOX HILL HOSPITAL   (United States)

Author keywords

Biopsy; Chemotherapy; Combined modality therapy; Cytology; Esophageal adenocarcinoma; Esophagectomy; Prognosis; Radiotherapy

Indexed keywords

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BIOPSY; CYTODIAGNOSIS; ESOPHAGOSCOPY; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; EVALUATION; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MALE; METHODOLOGY; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYTODIAGNOSIS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; RADIOTHERAPY, ADJUVANT; SENSITIVITY AND SPECIFICITY;

EID: 74249119297     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20051     Document Type: Article

References (41)

1. Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg. 1990; 77: 845-857.
2. Streitz JM Jr, Ellis FH Jr, Gibb SP, Balogh K, Watkins E Jr. Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann Surg. 1991; 213: 122-125.
3. Ellis FH Jr, Heatley GJ, Krasna MJ, Williamson WA, Balogh K. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in 3 consecutive 8-year intervals with improved staging criteria. J Thorac Cardiovasc Surg. 1997; 113: 836-846; discussion 846-848.
4. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002; 347: 1662-1669.
5. Swisher SG, Hunt KK, Holmes EC, Zinner MJ, McFadden DW. Changes in the surgical management of esophageal cancer from 1970 to 1993. Am J Surg. 1995; 169: 609-614.
6. Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR. Curative resection for esophageal adenocar-cinoma: analysis of 100 en bloc esophagectomies. Ann Surg. 2001; 234:520-530; discussion 530-531.
7. Adelstein DJ, Rice TW, Tefft M, et al. Aggressive concurrent chemoradiotherapy and surgical resection for proximal esophageal squamous cell carcinoma. Cancer. 1994; 74: 1680-1685.
8. Adelstein DJ, Rice TW, Becker M, et al. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer. 1997; 80: 1011-1020.
9. Meluch AA, Greco FA, Gray JR, et al. Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial. Cancer J. 2003; 9: 251-260.
10. Ku GY, Ilson DH. Preoperative therapy in esophageal cancer. Clin Adv Hematol Oncol. 2008; 6: 371-379.
11. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locore-gional esophageal carcinoma. J Clin Oncol. 2001; 19: 305-313.
12. Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 1998; 339: 1979-1984.
13. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg. 1988; 96: 242-248.
14. Bates BA, Detterbeck FC, Bernard SA, Qaqish BF, Tepper JE. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol. 1996; 14: 156-163.
15. Heath EI, Burtness BA, Heitmiller RF, et al. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol. 2000; 18: 868-876.
16. Ajani JA, Komaki R, Putnam JB, et al. A 3-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction. Cancer. 2001; 92:279-286.
17. Kim JH, Choi EK, Kim SB, et al. Preoperative hyperfractionated radiotherapy with concurrent chemotherapy in resectable esophageal cancer. Int J Radiat Oncol Biol Phys. 2001; 50: 1-12.
18. Hofstetter W, Swisher SG, Correa AM, et al. Treatment outcomes of resected esophageal cancer. Ann Surg. 2002; 236:376-384; discussion 384-385.
19. Denham JW, Steigler A, Kilmurray J, et al. Relapse patterns after chemo-radiation for carcinoma of the oesophagus. Clin Oncol (R Coll Radiol). 2003; 15: 98-108.
20. Donington JS, Miller DL, Allen MS, Deschamps C, Nichols FC 3rd, Pairolero PC. Tumor response to induction chemoradiation: influence on survival after esophagectomy. Eur J Cardiothorac Surg. 2003; 24:631-636; discussion 636-637.
21. Pedrazzani C, Pasini F, Giacopuzzi S, et al. Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal junction. Chir Ital. 2005; 57: 9-14.
22. Lagarde SM, de Boer JD, ten Kate FJ, Busch OR, Obertop H, van Lanschot JJ. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence. Ann Surg. 2008; 247: 71-76.
23. Yang Q, Cleary KR, Yao JC, et al. Significance of post-che-moradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen. Dis Esophagus. 2004; 17: 38-43.
24. Rohatgi PR, Swisher SG, Correa AM, et al. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer. 2005; 104: 1349-1355.
25. Batra SK, Kini SR, Schuman BM, Smith MJ. Evaluation of brush rinsings for the cytologic diagnosis of esophageal and gastric cancer. Gastrointest Endosc. 1982; 28: 23-25.
26. Hanson JT, Thoreson C, Morrissey JF. Brush cytology in the diagnosis of upper gastrointestinal malignancy. Gastrointest Endosc. 1980; 26: 33-35.
27. Mortensen NJ, Mackenzie EF. Accuracy of oesophageal brush cytology: results of a prospective study and multi-centre slide exchange. Br J Surg. 1981; 68: 513-515.
28. Qizilbash AH, Castelli M, Kowalski MA, Churly A. Endoscopic brush cytology and biopsy in the diagnosis of cancer of the upper gastrointestinal tract. Acta Cytol. 1980; 24: 313-318.
29. Young JA, Hughes HE, Lee FD. Evaluation of endoscopic brush and biopsy touch smear cytology and biopsy histology in the diagnosis of carcinoma of the lower oesophagus and cardia. J Clin Pathol. 1980; 33: 811-814.
30. Shaukat A, Mortazavi A, Demmy T, et al. Should preoperative, post-chemoradiotherapy endoscopy be routine for esophageal cancer patients? Dis Esophagus. 2004; 17: 129-135.
31. Schneider PM, Metzger R, Schaefer H, et al. Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer. Ann Surg. 2008; 248: 902-908.
32. Gill PG, Denham JW, Jamieson GG, Devitt PG, Yeoh E, Olweny C. Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery. J Clin Oncol. 1992; 10: 1037-1043.
33. Vogel SB, Mendenhall WM, Sombeck MD, Marsh R, Woodward ER. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg. 1995; 221:685-693; discussion 693-695.
34. Bedenne L, Seitz JF, Milan C, et al. Cisplatin, 5-FU and preoperative radiotherapy in esophageal epidermoid cancer. multicenter phase II FFCD 8804 study. Gastroenterol Clin Biol. 1998; 22: 273-281.
35. Lim JT, Truong PT, Berthelet E, et al. Endoscopic response predicts for survival and organ preservation after primary chemoradiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2003; 57: 1328-1335.
36. Lordick F, Ott K, Krause BJ, et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol. 2007; 8: 797-805.
37. Giovannini M, Seitz JF, Thomas P, et al. Endoscopic ultra-sonography for assessment of the response to combined radiation therapy and chemotherapy in patients with esoph-ageal cancer. Endoscopy. 1997; 29: 4-9.
38. Isenberg G, Chak A, Canto MI, et al. Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation. Gastrointest Endosc. 1998; 48: 158-163.
39. Swisher SG, Maish M, Erasmus JJ, et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg. 2004; 78: 1152-1160; discussion 1152-1160.
40. Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA, Eloubeidi MA. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg. 2005; 129: 1232-1241.
41. Agarwal B, Swisher S, Ajani J, et al. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol. 2004; 99: 1258-1266.